iShares MSCI ACWI ETF vs McKesson Corporation — how do they compare? iShares MSCI ACWI ETF trades at $161.26, while McKesson Corporation trades at $895.22 (market cap $105.14B). The key difference: McKesson Corporation pays a 0.42% dividend while iShares MSCI ACWI ETF pays none, and iShares MSCI ACWI ETF is trading nearer its 52-week high, McKesson Corporation nearer its low. Which is the better fit depends on your goals.
| ACWI | MCK | |
|---|---|---|
52-Week High | $161.44 | $995.69 |
52-Week Low | $132.04 | $659.01 |
Market Cap | — | $105.14B |
Sector | — | Health |
Enterprise Value | — | $111.67B |
Dividend Yield | — | 0.42% |
Trailing returns across standard periods
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index is a free float-adjusted market capitalization index designed to measure the combined equity market performance of developed and emerging markets countries.
Read more on ACWI →McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →